A systematic review of allometric scaling exponents for IgG mAbs

被引：0

作者：

Rowland, Simon Peter ^{[1
]}

Nixon, Emma ^{[2
]}

Mohan, Krithika ^{[3
]}

Wang, Qianwen ^{[4
]}

Yates, James W. T. ^{[2
]}

机构：

[1] Haleon, Bldg 5,First Floor, Weybridge KT13 0NY, Surrey, England

[2] GSK, DMPK Modelling, Stevenage, England

[3] DMPK Modelling, 1000 Winter St, Waltham, MA USA

[4] GSK, CPMS Infect Dis & Vaccine, London, England

来源：

XENOBIOTICA | 2024年 / 54卷 / 09期

关键词：

pharmacokinetics; allometric scaling; modelling mAb PK; cynomolgus monkey; mAb global scaling exponents; THERAPEUTIC MONOCLONAL-ANTIBODIES; HUMAN PHARMACOKINETICS; PREDICTION;

D O I：

10.1080/00498254.2024.2383925

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Increasing complexity of mAbs in development creates challenges in predicting human pharmacokinetic (PK) parameters from preclinical data. The aim of this analysis was to identify optimal allometric scaling exponents.Data were extracted from literature to create a central database (currently the largest available published database) of two-compartment model parameters for mAbs (n = 59) in cynomolgus monkey (CM) and human.Global allometric exponents were calculated and drug-dependent factors were investigated as potential variables in determining the optimal scaling factor.The global exponents for scaling CM mAb PK data were 0.74 (CL), 0.80 (CL with Fc-modified mAbs excluded), 0.44 (CL with Fc-modified mAbs only), 0.71 (Q), 1.12 (V1), and 0.99 (V2). These values are in line with previously published literature values.

引用

页码：609 / 614

页数：6

共 50 条

[11] Allometric scaling in animals and plants
Dreyer, O
Puzio, R
JOURNAL OF MATHEMATICAL BIOLOGY, 2001, 43 (02) : 144 - 156
[12] Allometric scaling and instability in electrospinning
He, JH
Wan, YQ
Yu, MY
INTERNATIONAL JOURNAL OF NONLINEAR SCIENCES AND NUMERICAL SIMULATION, 2004, 5 (03) : 243 - 252
[13] Obesity and Allometric Scaling of Pharmacokinetics
Douglas J. Eleveld
Johannes H. Proost
Anthony R. Absalom
Michel M. R. F. Struys
Clinical Pharmacokinetics, 2011, 50 : 751 - 753
[14] Allometric scaling of xenobiotic clearance: Uncertainty versus universality
Hu, TM
Hayton, WL
AAPS PHARMSCI, 2001, 3 (04):
[15] Allometric scaling of xenobiotic clearance: Uncertainty versus universality
Teh-Min Hu
William L. Hayton
AAPS PharmSci, 3 (4):
[16] Estimation issues in allometric scaling models
Bulmer, M
Fleetwood, K
MODSIM 2003: INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION, VOLS 1-4: VOL 1: NATURAL SYSTEMS, PT 1; VOL 2: NATURAL SYSTEMS, PT 2; VOL 3: SOCIO-ECONOMIC SYSTEMS; VOL 4: GENERAL SYSTEMS, 2003, : 1973 - 1978
[17] Allometric pharmacokinetic scaling: Towards the prediction of human oral pharmacokinetics
Feng, MR
Lou, XC
Brown, RR
Hutchaleelaha, A
PHARMACEUTICAL RESEARCH, 2000, 17 (04) : 410 - 418
[18] Emergence of allometric scaling in genealogical trees
Campos, PRA
de Oliveira, VM
Maia, LP
ADVANCES IN COMPLEX SYSTEMS, 2004, 7 (01): : 39 - 46
[19] Allometric scaling relationships in mouse placenta
Saghian, Rojan
Cahill, Lindsay S.
Debebe, Sarah K.
Rahman, Anum
Serghides, Lena
McDonald, Chloe R.
Weckman, Andrea M.
Kain, Kevin C.
Sled, John G.
JOURNAL OF THE ROYAL SOCIETY INTERFACE, 2022, 19 (196)
[20] Application of Allometric Scaling to Nanochelator Pharmacokinetics
Jones, Gregory
Zeng, Lingxue
Kim, Jonghan
ACS OMEGA, 2023, 8 (30): : 27256 - 27263

← 1 2 3 4 5 →